Cellebrite

CLBT

Market cap $4.19B

Cellebrite DI remains a long-term growth story, despite recent volatility and a modest stock decline since November 2024. CLBT's Q3 2025 earnings beat analyst expectations, with revenue up 18% year-over-year to $126 million and EPS of $0.14. Valuation and technical concerns persist, which could lead to further selling or an underperformance for the stock.

Portolan Capital increased its Cellebrite position by 1,407,818 shares, worth an estimated $28.65 million. The transaction equates to approximately 1.20% of 13F reportable assets under management (AUM).

Delaware-based Ashford Capital Management increased its position Cellebrite by 434,615 shares during the third quarter, adding an estimated $11.3 million in value to its stake. At quarter-end, Ashford reported holding 1.7 million shares of Cellebrite valued at $31.5 million as of September 30.

Cellebrite topped Wall Street's sales and earnings expectations for the third quarter. The company also raised its full-year guidance.

Cellebrite DI Ltd. ( CLBT ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Andrew Kramer - Vice President of Investor Relations Thomas Hogan - CEO & Director David Barter - Chief Financial Officer Marcus Jewell - Global Chief Revenue Officer Conference Call Participants Jeff Van Rhee - Craig-Hallum Capital Group LLC, Research Division Brian Essex - JPMorgan Chase & Co, Research Division Tomer Zilberman - BofA Securities, Research Division Louie Dipalma - William Blair & Company L.L.C.

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.13 per share.

ARR grew 19% to $439.8 million; Revenue grew 18% to $126.0 million Net income of $20.2 million supports non-GAAP net income of $36.9 million and adjusted EBITDA of $37.7 million, 29.9% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and nine months ending September 30, 2025.

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd (Nasdaq: CLBT), global leader in premier Digital Investigative and Intelligence solutions for the public and private sectors, today announced the appointment of Holly Windham as General Counsel and Chief Compliance Officer.

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2025 financial results after the U.S. market close on Wednesday, November 12, 2025.

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Autumn 2025 Release , evolving and advancing its Digital Investigation Platform with new integrations and powerful new capabilities that span from collection and review to advanced AI-powered analysis.